British Woman Celebrates a Year of Living Cancer-Free
... body's immune system, will target and fight any
leukemia cells that survive chemotherapy if they are ... bone marrow -- the site affected by the type of
leukemia she had -- confirmed that the TaNK cells were ... felt when she was diagnosed with acute myeloid
leukemia (AML) four years ago. AML is a cancer of the ...
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
... anti-tumor activity. Access is now working with
leukemia and lymphoma specialists to initiate additional Phase 2 clinical trials in acute myeloid
leukemia (AML) , acute lymphocytic
leukemia (ALL) and other indications. "The IND for ...
Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation
... avoid the use of radiation in acute lymphoblastic
leukemia treatment
MEMPHIS, Tenn., June 24 /PRNewswire-USNewswire/ -- Childhood acute lymphoblastic
leukemia (ALL) can be successfully treated using a ... ALL treatment to prevent recurrence of the
leukemia in the central nervous system (CNS).
...
Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
... a high response rate in acute lymphoblastic
leukemia (ALL) patients with minimal residual disease ... with B precursor
acute lymphoblastic
leukemia (ALL): Update of an ongoing Phase II
... treatment of patients with acute lymphoblastic
leukemia (ALL), and in a phase 1 clinical trial for the ...
Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
... anti-tumor activity. Access is working with
leukemia and lymphoma specialists at M.D. Anderson ... Phase 2 clinical trials in acute myeloid
leukemia (AML) , acute lymphocytic
leukemia (ALL) and other indications. Additionally, we ...
Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
... and relapsed or refractory chronic lymphocytic
leukemia (CLL). TRU-016 is the Company's proprietary ... for the treatment of CLL and small lymphocytic
leukemia (SLL). The objectives of the Phase 1 TRU-016 CLL ... was 67% and was as high as 98%. Two patients with
leukemia cutis had complete or partial clearance of skin ...
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
... benefit for patients with chronic lymphocytic
leukemia (CLL) whose disease is refractory to fludarabine ...
CLL is the most common form of adult
leukemia in the Western world, and the treatment of ...
About CLL
CLL is the most common adult
leukemia and one of the most common malignant lymphoid ...
Mutant Genes in High-Risk Childhood Leukemias Identified
... identify cases of childhood acute lymphoblastic
leukemia (ALL) that have a high risk of relapse and death. ... specific drugs that could treat this high-risk
leukemia subtype in children, particularly because such ... underlie such cases.
"Our studies of these
leukemia subtypes indicate ...
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
... to help children with acute myeloid
leukemia (AML). Dr. Ge is an Assistant Professor at the ... in bone marrow, accounts for one-fourth of acute
leukemia in children and is responsible for more than half of the
leukemia deaths in this population. Approximately 600 ...
Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
... Medicine employs Quest Diagnostics' blood-based
leukemia testing
MADISON, N.J., Feb. 20 ... years before the chronic form of lymphocytic
leukemia (CLL) develops, according to research published ... affected. Although CLL is the most common form of
leukemia in adults in Western countries, little is known ...
EntreMed Presents Initial Clinical Results for ENMD-2076
... Phase 1 studies underway, a Phase 1 study for
leukemia is being planned; and now orphan drug designation ... study and the expected commencement of the
leukemia study, the program covers a spectrum of potential ... start of the Phase 1 multiple myeloma and
leukemia studies will allow us to start treatment at a ...
St. Jude Finds More Than 100 Gene Variations Linked With Response to Leukemia Treatment
... in the body for children with acute lymphoblastic
leukemia
MEMPHIS, Tenn., Jan. 27 ... discovered in children with acute lymphoblastic
leukemia (ALL) scores of inherited genetic variations that ... of studying genetic variations acquired by
leukemia cells, scientists identified small genetic ...
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
... and PRINCETON, N.J., Jan. 22 /PRNewswire/ -- The
leukemia & Lymphoma Society (LLS) and Celator ... for treatment of adults with acute myeloid
leukemia (AML).
Through the partnership, LLS will ... of AML."
"We are very pleased that The
leukemia & Lymphoma Society sees the potential of ...
Gene Abnormality Found to Predict Childhood Leukemia Relapse
... of relapse in children with acute lymphoblastic
leukemia (ALL). Although the researchers caution that ... in the gene, called IKZF1 or IKAROS, lead to
leukemia relapse, the findings are likely to provide the ... the study, researchers analyzed genetic data on
leukemia cells obtained at diagnosis from 221 children ...
Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
... showed activity in high-risk chronic lymphocytic
leukemia (CLL) patients who have poor prognostic ... States are living with CLL, according to the
leukemia and Lymphoma Society. More people are living with ... Clinical Outcome of B-Cell Chronic Lymphocytic
leukemia Following Alemtuzumab Therapy: Retrospective ...
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
... newly diagnosed patients with chronic myeloid
leukemia
Two separate studies show rapid ... Philadelphia chromosome-positive chronic myeloid
leukemia (Ph+ CML) in early chronic phase achieved a ... MD, Professor of Medicine and Deputy Chair of
leukemia at the University of Texas MD Anderson Cancer ...
New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia
... PCR in patients with B-cell chronic lymphocytic
leukemia (CLL).
The study results will be given ... ASH conference:
Acute M y eloid
leukemia (AML)
Roger Lyons, M.D., ... older adult patients with acute myelogeneous
leukemia (AML) unlikely to benefit from standard induction ...
Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)
... (decitabine for injection) in acute myeloid
leukemia (AML), the most common form of leukemia. The ... patients with AML.
About Acute Myeloid
leukemia (AML)
Acute myeloid
leukemia is a rapidly progressing cancer of the blood and ...
Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
... the treatment of refractory chronic lymphocytic
leukemia (CLL). The results demonstrate the potential of ... 2009.
CLL is the most common form of
leukemia in the Western world,(2) and the treatment of ...
About CLL
CLL is the most common
leukemia and one of the most common malignant lymphoid ...
Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology
... diagnosed and relapsed/refractory acute myeloid
leukemia (AML). These data were presented today at two ... said Judith E. Karp, M.D., Director, Adult
leukemia Program at The Sidney Kimmel Comprehensive Cancer ... December 23, 2008.
About Acute Myeloid
leukemia
AML is a rapidly progressing cancer of the ...
Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes
... stem cell transplantation for patients with acute
leukemia is an unrelated adult donor whose tissue type ... of the outcomes of 1,240 adults with acute
leukemia (707 patients with acute myeloid
leukemia and 533 patients with acute lymphocytic leukemia) ...
Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
... the ASH press conference on treatment advances in
leukemia and lymphoma to respond to questions on this ... the ASH press conference on treatment advances in
leukemia and lymphoma. The embargo for this abstract will ... with relapsed or refractory chronic lymphocytic
leukemia were randomized to receive six 28-day cycles of ...
Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome
... types of rapid-growing cancers, particularly
leukemia or lymphoma. The syndrome develops when a ... of Medicine and Deputy Chair, Department of
leukemia at The University of Texas , MD Anderson Cancer ... Lymphoma (REAL) criteria, acute myeloid
leukemia (AML), chronic ...
Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
... as prognostic indicators for chronic lymphocytic
leukemia (CLL) and side effects such as ... for the treatment of B-cell chronic lymphocytic
leukemia (B-CLL). Leukine is indicated for use following ... 55 years and older with acute myelogenous
leukemia (AML) to shorten the time to neutrophil recovery ...
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
... patients with a life-threatening type of
leukemia to be featured in two oral sessions at ASH
... Diagnosed, Previously Untreated Chronic Myeloid
leukemia in Chronic Phase (CML-CP) Using Molecular ... chromosome-positive (Ph+) chronic myelogenous
leukemia (CML) in the chronic phase. Follow-up is limited ...
The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial
... WHITE PLAINS, N.Y., Dec. 3 /PRNewswire/ -- The
leukemia & Lymphoma Society (LLS) and Memgen, LLC ... refractory and/or 17p deleted chronic lymphocytic
leukemia (CLL).
Doctors at UCSD have already ... visit www.memgenbio.com .
About The
leukemia & Lymphoma Society
...
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
... from its studies of voreloxin in acute myeloid
leukemia (AML) will be presented during the 50th American ... kinases 2, 7 and 9, in both chronic lymphocytic
leukemia and multiple myeloma will be presented. ... Patients with Newly Diagnosed Acute Myeloid
leukemia (AML): Preliminary Safety and Clinical Responses ...
St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
... study finds the majority of acute lymphoblastic
leukemia relapse cases arise from a cell already present ... cancer cells of children with acute lymphoblastic
leukemia (ALL) that cause relapse. The finding offers a ... distinct cells, indicating that the relapsed
leukemia was actually an entirely new cancer.
...
Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
... in patients with newly diagnosed acute myeloid
leukemia (AML).
The first patient was enrolled by ... Ratios Delivered by CPX-351 to Human
leukemia Xenografts is Associated with Liposome-Mediated ... Intracellular Delivery of Encapsulated Agents to
leukemia Cells, and Increased Efficacy will be presented ...
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
... Philadelphia chromosome-positive
chronic myeloid
leukemia (Ph+ CML) in the chronic phase. Follow-up ... relapsed or refractory Ph+ acute lymphoblastic
leukemia (Ph+
ALL); adult patients with ... syndrome (HES) and/or
chronic eosinophilic
leukemia (CEL) who have the FIP1L1-PDGFRa fusion
kinase ...
Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
... options."
Dr. Norbert Vey, Head of the
leukemia Service of the Institut
Paoli-Calmettes and Chief ... is a very serious form of
leukemia from which few patients can
be cured currently. ... untreated de novo
poor-risk acute myelogenous
leukemia (AML). The Company is also conducting
clinical ...
Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
... for patients with
B-cell chronic lymphocytic
leukemia and other hematologic and solid-tumor
cancers."
... or relapsing B-cell
Chronic Lymphocytic
leukemia ("CLL"). As previously announced, dosing in ... About CLL
CLL is the second most common type of
leukemia in adults. (2) The
American Cancer Society ...
Aegera Initiates a Fifth Phase 1 and 2 Clinical Trial for AEG35156
... made possible, in part, by funding from The
leukemia &
Lymphoma Society, is entitled "A Phase 1-2, ... with relapsed or refractory chronic
lymphocytic
leukemia (CLL), small lymphocytic lymphoma (SLL) and ... indications. I must also thank, once again, The
leukemia & Lymphoma
Society for their financial support of ...
University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
... WHITE PLAINS, N.Y., July 7 /PRNewswire/ -- The
leukemia & Lymphoma
Society has awarded a $550,000 grant ... in established and
new laboratories.
About The
leukemia & Lymphoma Society
The
leukemia & Lymphoma Society(R), headquartered in White ...
The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
... WHITE PLAINS, N.Y., June 18 /PRNewswire/ -- The
leukemia & Lymphoma
Society (LLS) and Memgen jointly ... is very pleased to be working with The
leukemia & Lymphoma Society.
ISF35 has the potential to ... visit http://www.memgenbio.com .
About The
leukemia & Lymphoma Society
...
Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
... of voreloxin in relapsed or refractory
acute
leukemia patients will be presented at the 13th Congress ... cytarabine in
relapsed/refractory acute myeloid
leukemia (AML) patients. In addition,
data from the ... of SNS-032 in
patients with chronic lymphocytic
leukemia and multiple myeloma will be
presented at EHA.
...
Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
... chromosome-positive chronic myeloid
leukemia to be presented
EAST HANOVER, N.J., May 15 ... with imatinib-resistant chronic myeloid
leukemia in chronic phase (Abstract #7010: Monday, June ... chromosome-positive chronic myeloid
leukemia (Ph+ CML).
ASA404 is an investigational ...
The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement
... WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- The
leukemia & Lymphoma
Society (LLS) and Anjin Group, Inc. ... see http://www.anjingroup.com .
About The
leukemia & Lymphoma Society
The
leukemia & Lymphoma Society(R), headquartered in White ...
Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
... and in vivo
activity as well as tolerability in
leukemia xenograft models, and further
elucidating the NEI ... Export Inhibitors
(NEIs) in Multiple Murine
leukemia Models" presented data from NEI
compounds tested ... models of leukemia, including acute
lymphoblastic
leukemia (ALL) and acute ...
St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
... in childhood acute lymphoblastic
leukemia (ALL) could offer a
pathway to predicting such ... have successfully used laboratory studies of
leukemia cells
to explore the basis of resistance in other ... genes was not surprising
because the drug kills
leukemia cells by interfering with their ability ...